drugset
Drugs / MVA-CDMR
last change Jun 2015 re-read 3 minutes ago

MVA-CDMR

also known as Modified Vaccinia Ankara
Developed for
HIV infectious disease
Investigated by
Imperial College London · Instituto Nacional de Saúde, Mozambique · Karolinska Institutet · Ludwig-Maximilians - University of Munich · Mbeya medical research program · Medical Research Council
+4 more · Muhimbili University of Health and Allied Sciences · National Institute for Medical Research, Tanzania · Swedish Institute for Infectious Disease Control · US Military HIV Research Program

Trials 1

today NCT01697007 · Ph 2
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01697007 Nov 2012 → Dec 2014 HIV infectious disease Muhimbili University of Health and Allied Sciences Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MVA-CDMR ClinicalTrials.gov intervention name — accepted as the source's own label NCT01697007 ↗
Known as Modified Vaccinia Ankara “Modified Vaccinia Ankara (MVA-CDMR)” NCT01697007 ↗
Route Intramuscular “IM MVA Boosting” NCT01697007 ↗